Novo Nordisk Targets 'Obesity Disease Market' Despite Commercial Doubts

 
• By Sten Stovall
  
Overweight stomach (shallow focus)
Diabetes Fighter Novo Nordisk Says It Will Increasingly Target Obesity • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business